Print

Print


August 18, 2000

New Hope for Parkinson's Disease



Approximately 1 million Americans suffer from Parkinson's disease, a
neurological disorder that begins with only a slight tremor but eventually
produces rigidity, a shuffling gait, and difficulty speaking.

With a cure still undiscovered, the "gold standard" for treatment of
Parkinson's disease is l-dopa, a drug that helps to control tremor and
reduce rigidity by increasing the amount of dopamine in the brain.

While l-dopa relieves symptoms temporarily, this drug is far from ideal. It
has undesirable side effects, including severe nausea, dizziness, and in
some cases liver damage. Its effectiveness diminishes over time, and the
drug itself increases the generation of free radicals that worsen the
disease in the long run.

Glutathione, an Effective New Therapy
At the Whitaker Wellness Institute, we are using a promising new therapy
called intravenous glutathione to help slow the process of nerve cell
degeneration.

Levels of glutathione, a naturally occurring brain-protecting antioxidant,
are significantly decreased in patients with Parkinson's disease, with the
deficiency occurring in the portion of the brain where dopamine-generating
neurons are concentrated.

Clinical studies have demonstrated that boosting levels of glutathione
through intravenous administration slows the progress of the disease
significantly. We have seen evidence of this firsthand.

Effects of Therapy Are Rapid and Dramatic
One of our patients arrived for his first treatment in a wheelchair, with a
significant tremor in his left arm. After his third treatment, he was
walking around the clinic, arms swinging, the tremor in his left arm
completely gone.

In addition to its effects on tremors and mobility, IV glutathione usually
improves speech and alleviates depression, which is a common side effect of
Parkinson's disease.

Glutathione can be beneficial even when administered several years after the
onset of Parkinson's disease. Injections take about 15 minutes and are
repeated three to seven times per week. Glutathione therapy is extremely
safe and without side effects.

David Perlmutter, M.D., has done much to study and promote the use of IV
glutathione in Parkinson's disease. For more information on this therapy,
click here. To learn more about the programs offered at the Whitaker
Wellness Institute, click here.



----------------------------------------------------------------------------
----
HOME | TOP OF PAGE | AFFILIATE PROGRAMS
HEALTH TERMS EXPLAINED | CONTACT US | THE FINE PRINT


[log in to unmask]